Delivery Order SPE2DB20D3103-SPE2DB24FN5P1

Award Date 4/24/24
Potential Completion Date 4/25/24
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $5,130.55. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pens and has a completion date of February 19, 2025. This award is under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $4,169.21 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Trulicity 0.75 mg/0.5 ml pens. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to DLA facilities...
The Defense Logistics Agency (DLA) awarded a $3,350.43 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 0.75 mg/0.5 ml pens. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the provision of Trulicity 3 mg/0.5 ml pens. The fixed-price contract has a ceiling value of $8,998.68 and an ultimate completion date of August 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which enables...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $5,805.60 contract is for the supply of Trulicity 0.75 mg/0.5 ml pens, a brand name medication. The contract is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and runs through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Trulicity 0.75 mg/0.5 ml pens. The contract has a ceiling value of $1,741.68 and a performance period through April 11, 2024. This award is a task order under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00, for delivering pharmaceuticals and medical...
The Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 0.75 mg/0.5 ml pens. The contract has a ceiling value of $1,161.12 and a period of performance through August 28, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows the DLA Troop Support Medical to efficiently procure a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,322.36 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Trulicity 0.75 mg/0.5 ml pen medication. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a $3,804.24 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 0.75 mg/0.5 ml pens. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. The IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $1,306.26 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 4.5 mg/0.5 ml pens. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FN5P1
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 0.75 mg/0.5 ml pens. The contract has a ceiling value of $7,235.30 and an ultimate completion date of April 25, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:08 AM